Wikipedia -WSS

Wikipedia

author：comprehensive 2025-10-01 23:31:07 - browse：5862

Illustration of a person walking across a tightrope, trying to balance. — Adobe

Hospitals are telling government officials it would be illegal to claw back $7.8 billion as part of a remedy that is making hospitals whole over underpaid drug discounts — and they may sue if that plan goes into effect.

The industry is walking a tightrope by trying to maximize the amount of money hospitals can keep. Lobbyists are praising federal officials for agreeing to dole out billions of dollars in future, lump-sum payments, but they are also pressuring Medicare not to offset a penny of those funds.

For several years during the Trump administration, Medicare cut payments for hospitals’ drugs under the federal 340B drug discount program, but the Supreme Court invalidated that policy in 2018. In July, Medicare proposed a solution: Hospitals would get $9 billion to cover what they are owed under the 340B program, but to offset those costs, the government would recoup $7.8 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Roche acquires Telavant from Roivant, adding experimental IBD treatment

explore

WSS

Dems pitch expanding Medicare power to negotiate drug prices

Results on Novartis prostate cancer therapy could expand its use

Search called off for baby washed away in Pennsylvania flash flood

In the gardens at Boston Children's Hospital, families find sanctuary

Roivant's CEO is a star, but biotech's black hole persists

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

focus

Wikipedia

focus

How one medical school became remarkably diverse

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

Moonlake's readout produced a cash windfall. Risks remain

Will the FTC rein in IQVIA's health data empire?

Heart attack and stroke risk calculators need revising

How doctors’ personal politics affect patients

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Trump demands the U.S. pay no more for drugs than other countries … again

What it's like to live with paralysis for one psychologist

focus

CDC Director Mandy Cohen on transparency, trust, and health

Smaller biotechs seek to piggyback on weight loss drug boom

Former reverend arrested for allegedly killing 8

Rise in cancer among younger people worries and puzzles doctors

Roivant's CEO is a star, but biotech's black hole persists

ADCs take center stage as promising cancer treatments

knowledge

explore

hotspot

hotspot